Age-Related Macular Degeneration
398
42
61
221
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
80 trials with published results (20%)
Research Maturity
221 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.8%
39 terminated out of 398 trials
85.0%
-1.5% vs benchmark
14%
54 trials in Phase 3/4
36%
80 of 221 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 221 completed trials
Clinical Trials (398)
Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration
Age-Related Eye Disease Study (AREDS) Follow-Up
Study of Dark Adaptation in Age-Related Macular Degeneration
Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration
Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy
Effects of Goji vs. Fiber on Macular Degeneration
A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
AI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care
Visual Remapping to Aid Reading With Field Loss
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration
National Eye Institute Biorepository for Retinal Diseases
Stem Cell Ophthalmology Treatment Study II
Multicenter Real-life Observational Study Switched Aflibercept or Ranibizumab to Faricimab in Patients With AMD.
An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration